Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Athlete’s Foot Treatment Market Share, Size, Insights, Analysis, Growth, Forecast: By Drug Class: Antifungals, Corticosteroids, Others; By Application Mode: Creams, Sprays, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; Market Dynamics; Regional Analysis; Supplier Landscape; 2023-2031

Global Athlete’s Foot Treatment Market Outlook

The Athlete’s foot treatment market size is driven by the rising prevalence of fungal skin diseases. The prevalence of fungal skin diseases was nearly 802 million in 2022. The prevalence of fungal skin diseases is likely to grow at a CAGR of 7% during the forecast period of 2023-2031. The prevalence of fungal skin diseases is likely to reach close to 1475 million by 2031.

 

Athlete’s Foot: Disease Insights

The Athlete’s foot or Tinea pedis is the transmissible fungal infection that mainly affects the foot’s skin. This disease also spreads to hands and toenails. It is named ‘Athlete’s foot’ because it is highly prevalent in athletes. The causative agent of the Athlete’s foot is Tinea fungus. The warm and humid climates facilitate the growth of these fungi. This disease can be caused by coming in direct contact with the infected person or with the infected objects.

 

Certain factors, like walking barefoot in public places, sharing objects with the infected person, wearing tight footwear, and keeping wetty feet for longer periods facilitate the growth of tinea fungus. Thus, these factors increase the chances of Athlete’s foot disease.

 

The signs and symptoms of an Athlete’s foot include blisters on the feet, dry feet skin, discoloured toenails, itching between the toes, and cracking feet skin.

 

Diagnostic and Therapeutic Interventions

Monitoring of symptoms helps in the diagnosis of the Athlete’s foot. A skin lesion potassium hydroxide test is mainly done to confirm this disease. In this test, a small area of infected skin is scrapped and placed in potassium hydroxide. Potassium hydroxide damages the healthy cells and leaves the infected cells behind. These infected cells can be analyzed under a microscope for further evaluation.

 

The treatment methods for Athlete’s foot depend on the severity of the disease. This is mainly treated with the help of over-the-counter antifungal medications. Some examples of such drugs are Miconazole, Clotrimazole, and Tolnaftate. These drugs are applied through topical routes. Oral antifungals, topical steroids, and oral antibiotics may also be prescribed for the Athlete’s foot disease treatment market. Example of such drugs are Fluconazole and Itraconazole.

 

According to the Athlete’s foot treatment market research report, the market can be categorised into the following segments:

 

Market Breakup by Drug Class

  • Antifungals
  • Corticosteroids
  • Others

 

Market Breakup by Application Mode

  • Creams
  • Sprays
  • Others

 

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Global Athlete’s Foot Treatment Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

Athlete’s Foot Treatment Market Scenario

The growth of the Athlete’s foot treatment market is driven by the increasing prevalence and incidence of Athlete’s foot disease. Due to the increasing cases, the demand for the treatment rises, thus helping in the expansion of the market. According to World Health Organization, 70 per cent of the world’s population will be diagnosed with Athlete’s foot disease at some point.

 

The easy availability of over-the-counter drugs is also anticipated to drive the market development. Novel product launches, approvals, and low-cost therapeutic strategies boost the Athlete’s foot treatment market growth.

 

Anti-Fungal Segment to Dominate the Drug Class

Among the drug class, antifungals are anticipated to dominate the global market because it provides the first-line treatment for Athlete’s foot disease. The easy accessibility of antifungals is also boosting the market growth.

 

North America and the Asia Pacific to Hold Significant Shares in the Athlete’s Foot Treatment Market

 

North America accounts for the largest share of the global market owing to the increasing incidence of Athlete’s foot disease, raising awareness and better healthcare facilities.

 

The Asia Pacific region is projected to grow at the highest growth rate during the forecast period. This is due to the increasing developments in the healthcare sector, the rising geriatric population, and more significant investments by the key players.

 

Therapeutic Landscape

The treatment is prescribed based on the affected area, disease severity, and diagnostic test assessment. There are several medications and drugs approved by regulatory authorities for the treatment of Athlete’s foot disease. These drugs are available in the form of creams, tablets, powders, liquids, and sprays.

 

Effective Medications and Therapies: Antifungal Drugs, Oral Antibiotics, and Home Remedies

The first line treatment for Athlete’s foot disease is the administration of over-the-counter anti-fungal medicines. These drugs act by stopping the growth of the tinea fungi and hence, prevent the further progression of the disease. Some anti-fungal medicines are Miconazole, Terbinafine, Clotrimazole, Butenafine, and Tolnaftate.

 

Prescription drugs are also incorporated for the management of Athlete’s foot disease. This category includes high-strength topical drugs like miconazole, topical steroidal medications, oral antifungal drugs like terbinafine and oral antibiotics. These drugs show their action by limiting fungal growth and managing inflammation.

 

Alternative therapies and home remedies contribute to the market. The application of tea tree oil has been found effective for treating Athlete’s foot disease. Several home remedies like washing the feet at regular intervals, proper drying and soaking feet in vinegar or salt water have also shown some promising effects in disease management.

 

Clinical Trials Driving the Athlete’s Foot Treatment Market Growth During the Forecast Period

The emerging Athlete’s foot disease therapies seem promising in commercial aspects. The extensive research and developmental activities will facilitate the discovery of novel products. The novel targeted therapies are expected to attract the attention of key players and thus propel the market expansion during the forecast period.

 

Novan, a novel topical medication, is under Phase III clinical trials. Nitric oxide is the active ingredient of Novan that supply the necessary therapeutic response and regulates inflammation.

 

Emerging Therapies: Fungal Eliminators, Innovative Sprays, Novel Medications

The discovery of nutritional supplements for managing the Athlete’s foot is one of the emerging therapies. PureHealth Research, a key player, developed a fungal eliminator nutritional supplement to eradicate nail fungus. This supplement incorporates anti-bacterial and anti-fungal properties.

 

The development of more efficient and innovative sprays by School’s Wellness has recently been approved for treating Athlete’s foot disease. The spray provides several therapeutic benefits like relief in burning, itching and pain without leaving any powdery residue behind.

 

There are many new drugs and medications under clinical evaluation and development. The approval of these drug products is anticipated to drive the market size. 

 

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the Athlete’s foot treatment market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • Cipla Limited
  • Johnson & Johnson
  • GSK plc
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Bayer AG
  • Enzon Pharmaceuticals, Inc
  • Abbott Laboratories

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2016-2022
Forecast Period 2023-2031
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Application Mode
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Antifungals
  • Corticosteroids
  • Others
Breakup by Application Mode
  • Creams
  • Sprays
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cipla Limited
  • Johnson & Johnson
  • GSK plc
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Bayer AG
  • Enzon Pharmaceuticals, Inc
  • Abbott Laboratories

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
        1.1.1     Research Objectives
        1.1.2     Key Findings of the Report
    1.2    Limitations of the Study and Scope for Future Research
2    Research Methodology
3    Executive Summary
4    Global Athlete’s Foot Overview

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway 
5    Patient Profile
    5.1    Patient Profile Overview
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Global Athlete’s Foot Treatment Market
    6.1    Global Athlete’s Foot Treatment Market Overview
    6.2    Global Athlete’s Foot Treatment Market Analysis 
        6.2.1     Market Overview
            6.2.1.1    Global Athlete’s Foot Treatment Market Historical Value (2016-2022) 
            6.2.1.2    Global Athlete’s Foot Treatment Market Forecast Value (2023-2031)
    6.3    Global Athlete’s Foot Treatment Market by Drug Class
        6.3.1    Market Overview
            6.3.1.1    Antifungals
            6.3.1.2    Corticosteroids
            6.3.1.3    Others
    6.4    Global Athlete’s Foot Treatment Market by Application Mode
        6.4.1    Market Overview
            6.4.1.1     Creams
            6.4.1.2     Sprays
            6.4.1.3     Others 
    6.5    Global Athlete’s Foot Treatment Market by Distribution Channel
        6.5.1    Market Overview
            6.5.1.1    Hospital Pharmacies 
            6.5.1.2    Retail Pharmacies 
            6.5.1.3    Online Pharmacies
    6.6    Global Athlete’s Foot Treatment Market by Region
        6.6.1     Market Overview
            6.6.1.1    North America 
                6.6.1.1.1    Historical Trend (2016-2022)
                6.6.1.1.2    Forecast Trend (2023-2031)
            6.6.1.2    Europe
                6.6.1.2.1    Historical Trend (2016-2022)
                6.6.1.2.2    Forecast Trend (2023-2031)
            6.6.1.3    Asia Pacific
                6.6.1.3.1    Historical Trend (2016-2022)
                6.6.1.3.2    Forecast Trend (2023-2031)
            6.6.1.4    Latin America
                6.6.1.4.1    Historical Trend (2016-2022)
                6.6.1.4.2    Forecast Trend (2023-2031)
            6.6.1.5    Middle East and Africa
                6.6.1.5.1     Historical Trend (2016-2022)
                6.6.1.5.2    Forecast Trend (2023-2031)
7    North America Athlete’s Foot Treatment Market
    7.1    United States of America
        7.1.1    Historical Trend (2016-2022)
        7.1.2    Forecast Trend (2023-2031)
    7.2    Canada 
        7.2.1    Historical Trend (2016-2022)
        7.2.2    Forecast Trend (2023-2031)
8    Europe Athlete’s Foot Treatment Market
    8.1    United Kingdom
        8.1.1    Historical Trend (2016-2022)
        8.1.2    Forecast Trend (2023-2031)
    8.2    Germany
        8.2.1    Historical Trend (2016-2022)
        8.2.2    Forecast Trend (2023-2031)
    8.3    France
        8.3.1    Historical Trend (2016-2022)
        8.3.2    Forecast Trend (2023-2031)
    8.4    Italy
        8.4.1    Historical Trend (2016-2022)
        8.4.2    Forecast Trend (2023-2031)
9    Asia Pacific Athlete’s Foot Treatment Market
    9.1    China
        9.1.1    Historical Trend (2016-2022)
        9.1.2    Forecast Trend (2023-2031)
    9.2    Japan
        9.2.1    Historical Trend (2016-2022)
        9.2.2    Forecast Trend (2023-2031)
    9.3    India
        9.3.1    Historical Trend (2016-2022)
        9.3.2    Forecast Trend (2023-2031)
    9.4    ASEAN
        9.4.1    Historical Trend (2016-2022)
        9.4.2    Forecast Trend (2023-2031)
    9.5    Australia
        9.5.1    Historical Trend (2016-2022)
        9.5.2    Forecast Trend (2023-2031)
10    Latin America Athlete’s Foot Treatment Market
    10.1    Brazil
        10.1.1    Historical Trend (2016-2022)
        10.1.2    Forecast Trend (2023-2031)
    10.2    Argentina
        10.2.1    Historical Trend (2016-2022)
        10.2.2    Forecast Trend (2023-2031)
    10.3    Mexico
        10.3.1    Historical Trend (2016-2022)
        10.3.2    Forecast Trend (2023-2031)
11    Middle East and Africa Athlete’s Foot Treatment Market
    11.1    Saudi Arabia
        11.1.1    Historical Trend (2016-2022)
        11.1.2    Forecast Trend (2023-2031)
    11.2    United Arab Emirates
        11.2.1    Historical Trend (2016-2022)
        11.2.2    Forecast Trend (2023-2031)
    11.3    Nigeria
        11.3.1    Historical Trend (2016-2022)
        11.3.2    Forecast Trend (2023-2031)
    11.4    South Africa
        11.4.1    Historical Trend (2016-2022)
        11.4.2    Forecast Trend (2023-2031)
12    Current Scenario Evaluation and Regulatory Framework
    12.1    Emerging Therapies and Clinical Trials
    12.2    Patent Landscape 
        12.2.1    Patent Overview
            12.2.1.1    Patent Status and Expiry
            12.2.1.2    Timelines from Drug Development to Commercial Launch
            12.2.1.3    New Drug Application
                12.2.1.3.1    Documentation and Approval Process
    12.3    Cost of Treatment
    12.4    Regulatory Framework
        12.4.1    Regulatory Overview
            12.4.1.1    US FDA
            12.4.1.2    EU EMA
            12.4.1.3    INDIA CDSCO
            12.4.1.4    JAPAN PMDA
            12.4.1.5    Others
13    Challenges & Unmet Needs
    13.1    Treatment Pathway Challenges
    13.2    Compliance and Drop-Out Analysis
    13.3    Awareness and Prevention Gaps
14    Global Athlete’s Foot Treatment Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model 
    14.4    Key Demand Indicators 
    14.5    Key Price Indicators 
    14.6    Industry Events, Initiatives & Trends 
    14.7    Value Chain Analysis
15    Supplier Landscape
    15.1    Cipla Limited
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    Johnson & Johnson
        15.2.1    Company Overview
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications
    15.3    GSK plc
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Mylan N.V.
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Novartis AG
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Pfizer Inc.
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    Merck & Co., Inc.
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    Sanofi S.A.
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    Bayer AG
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
    15.10    Enzon Pharmaceuticals, Inc
        15.10.1    Company Overview
        15.10.2    Product Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisitions
        15.10.5    Certifications
    15.11    Abbott Laboratories
        15.11.1    Company Overview
        15.11.2    Product Portfolio
        15.11.3    Demographic Reach and Achievements
        15.11.4    Mergers and Acquisitions
        15.11.5    Certifications
16    Recommendations and Discussion
17    Global Athlete’s Foot Treatment Drugs Distribution Model (Additional Insight)

    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment
18    Payment Methods (Additional Insight)
    18.1    Government Funded
    18.2    Private Insurance
    18.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Based on the drug class, the market is segmented into corticosteroids and anti-fungal, among others. 

The different regions in this market are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is anticipated to hold a significant share of the global market during the forecast period.

Anti-inflammatory medications, over-the-counter drugs, topical steroids, antibiotics, and home remedies help alleviate and manage Athlete’s foot disease.

The distribution channels in the market are hospital pharmacies, retail pharmacies and online pharmacies.

Increasing prevalence of Athlete’s foot, easy availability of over-the-counter drugs, increased research and developmental activities, and better awareness are the driving factors in the market.

The key players in the market include Cipla Limited, Johnson & Johnson, GSK plc, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Bayer AG, Enzon Pharmaceuticals, Inc, and Abbott Laboratories, among others.

Purchase Full Report

Mini Report

$2499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$6499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$7999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER